Your browser doesn't support javascript.
loading
Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma.
Saliby, Renee Maria; El Zarif, Talal; Bakouny, Ziad; Shah, Valisha; Xie, Wanling; Flippot, Ronan; Denize, Thomas; Kane, M Harry; Madsen, Katrine N; Ficial, Miriam; Hirsch, Laure; Wei, Xiao X; Steinharter, John A; Harshman, Lauren C; Vaishampayan, Ulka N; Severgnini, Mariano; McDermott, David F; Lee, Gwo-Shu Mary; Xu, Wenxin; Van Allen, Eliezer M; McGregor, Bradley A; Signoretti, Sabina; Choueiri, Toni K; McKay, Rana R; Braun, David A.
Afiliación
  • Saliby RM; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • El Zarif T; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Bakouny Z; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Shah V; Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Xie W; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Flippot R; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Denize T; Department of Cancer Medicine, Gustave Roussy, Paris Saclay University, Villejuif, France.
  • Kane MH; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Madsen KN; Yale Center of Cellular and Molecular Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Ficial M; Yale Center of Cellular and Molecular Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Hirsch L; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Wei XX; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Steinharter JA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Harshman LC; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Vaishampayan UN; Larner College of Medicine, University of Vermont, Burlington, Vermont.
  • Severgnini M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • McDermott DF; Surface Oncology, Cambridge, Massachusetts.
  • Lee GM; University of Michigan/Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.
  • Xu W; Center for Immuno-Oncology Immune Assessment Laboratory at the Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Van Allen EM; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • McGregor BA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Signoretti S; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • McKay RR; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Braun DA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Cancer Immunol Res ; 11(8): 1114-1124, 2023 08 03.
Article en En | MEDLINE | ID: mdl-37279009

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Límite: Humans Idioma: En Revista: Cancer Immunol Res Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Límite: Humans Idioma: En Revista: Cancer Immunol Res Año: 2023 Tipo del documento: Article